Syndex

The recent developments in the Middle East highlight the value of a diversified portfolio and a disciplined, long-term investment approach. In this environment of sustained sensitivity to policy shifts, geo-political tensions and macroeconomic trends, private markets often demonstrate distinct dynamics compared to the volatility seen in public markets. Prioritising high-quality investments with strong fundamentals remains essential for pursuing resilient, long-term returns.

See our markets for WHOLESALE private market opportunities:

Discover Interesting Investments The Syndex marketplace brings you investment opportunities in private market assets, such as commercial property, agriculture, horticulture and technology.

Our marketplace has plenty of investment options right now. If you want to put your capital to work, take a look.

For wholesale investment opportunities:
https://www.syndex.exchange/markets

(image shows Ecliptic Venture Capital, Wolfbrook Capital Fixed Income Fund and Juna)

We’ve introduced a new Active Investor Plus filter on our Markets page. This programme encourages offshore investors seeking New Zealand residency to invest in private New Zealand businesses and approved funds.

At Syndex, we are both a facilitator of AIP investment and a beneficiary. NZTE has encouraged us to list approved AIP companies and funds seeking AIP investment on our Opportunities page, providing visibility for both local and AIP investors looking to participate in the programme.

See our markets page here: https://www.syndex.exchange/markets

Inhibit Coatings - investment opportunity for wholesale investors:
Inhibit has developed and patented low cost antimicrobial medical grade polyurethanes that are a drop-in replacement for existing medical plastics. The value proposition has been validated with world leading clinicians and medical device manufacturers. Working with partners, the technology is currently being integrated into device applications that include, wound care, cardiac implantables, sutures, and catheters. Inhibit is now scaling to meet commercial manufacturing volumes and complete FDA safety testing.

For more info: https://www.syndex.exchange/investment-opportunities/inhibit-coatings-limited

Inhibit Coatings Limited Inhibit Coatings Limited Units